chrisvoncsefalvay/vaers-outcomes huggingface dataset:
her blood pressure started to go up; This is a spontaneous report from a contactable consumer (the patient). A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported since the caller unwilling to complete the report) via an unspecified route of administration on 13Feb2021 at single dose for COVID-19 immunisation. Medical history included blood pressure (abnormal) (reported as "she has been on same dosage of blood pressure medicine for years"). The patient's concomitant medications were not reported. After patient had her second dose Pfizer COVID 19 vaccination on 13Feb2021 that shortly afterwards, a couple weeks later, even though caller has been on same blood pressure medications for many years on the same dosage, her blood pressure has gone up starting around the 09Mar2021 (pending clarification). She reported that it went up so high she had to go to the Emergency Room on Saturday night. The doctor in the Emergency Room told her, "there is no way this could be associated with the vaccine." She was currently taking double the amount of blood pressure medication she was prior to receiving the Pfizer COVID-19 vaccine. She would like to report this event and also inquire if this side effect has been reported to be associated with the vaccine. As of 14Apr2021, caller stated that all of a sudden her blood pressure has become so elevated she had to go to the emergency room on Saturday night. The event onset date was provided as "10Apr2021" (pending clarification)). Caller stated that she would like to find out if anyone else has experienced this or file a report about it. The outcome of the event was unknown. The case was not serious.  Information on the lot/batch number has been requested.
The same day (1/31/23) of the vaccines pt. had weak and tingly legs, someone else had to drive her home.   Throughout a week the numbness started getting worse on pt.'s left side and she went to an outpatient center which diagnosed her with a pinched nerve due to her hernia history. (2/8/23)  The next day I (son) noticed signs of stroke (left paralysis and neglect, weakness, confusion) and rushed her to the hospital (2/9/23) where they cleared her via CT scan + inpatient stay (2/10/23). There was no MRI done. They discharged with reasons of hyperglycemia since they could not determine a TIA stroke had occured.  A few days later (2/13/23) pt.'s left side was worse with complete left paralysis and left neglect. After 5 days of hospital tests and observations she was discharged to a rehab - where she is still at - to recover from multiple strokes.
pt recv vax in AM about 11AM started w/fever late evening about 5;fever got u p to 104;went to ER had staring glaze in eyes;MD there said it probably was d/t fever;
My daughter gets febrile Seizures; but with the hep A vaccine, she did not get fever, but she was standing by the bed and fell down and was having a seizure.
Cramping and dull pain in upper arm, soreness when laying on left side, and injection site has become red. Upper arm slightly warm and swollen to the touch.
Pt's arm was swollen (softball size), red, warm, and tender. She experienced tiredness. No fever or nausea.
Around 4:15 I noticed a rash on both of my forearms. It wasn't hives, nor was it itchy, but it start right after I got my vaccine. I left the hospital at 4:35 that's when I felt a headache. It is midnight and my headache has not gone away. It comes on flares. Around 5 I started feeling confused. I feel like I have brain fog. It's hard for me to concentrate and stay focused. I feel like I'm in a daze. I can't lift up my right arm. I also noticed when I turn my wrist it'll go numb. It's been doing that since about 5pm as well.
I developed COVID-19 symptoms (light cough, fatigue) on August 09, 2022.  I tested positive using a home test.  I attended Urgent Care on August 13, 2022 and was examined by PA-C.  I received a prescription for molnupiravir and took the whole course as prescribed.  The cough ended in 3 days but I remained fatigued for 18 days. It took until August 28 before I had a negative COVID-19 home test.  A second home test on August 30 corroborated the test on August 28.
This case was reported by a consumer via call center representative and described the occurrence of gastrointestinal upset in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced gastrointestinal upset, fever and general body pain. On an unknown date, the outcome of the gastrointestinal upset, fever and general body pain were unknown.  It was unknown if the reporter considered the gastrointestinal upset, fever and general body pain to be related to SHINGRIX. Additional details were received as follows: The patient experienced gastrointestinal (GI) upset, fever and aches all over. The patient asked would the 2nd dose of SHINGRIX knock him down like above mentioned events.
Patient reports low grade fever and pain for a week and so went to her PCP who thought she had a reaction to the shot. Due to pain, she was referred to ortho and per the specialist, the pain was because the shot was given way high in the arm and too close to the shoulder bone. She is doing physical therapy. The injury is related to SIRVA.
Patient received Janssen Vaccine 03/05/21 from a different provider,  tried to get second pfizer 08/12/21
Evening of inj - developed chills, fever muscle weakness from waist down. Pt didn't report event until 10/6/11.
A woman dies of a rare brain disorder after second dose of Pfizer; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A 60-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 (Dose:1, MANUFACTURER UNKNOWN), for Covid-19 Immunization. The following information was reported: CEREBRAL DISORDER (death), outcome "fatal", described as "A woman dies of a rare brain disorder after second dose of Pfizer". The patient date of death was Feb2021. Reported cause of death: "A woman dies of a rare brain disorder after second dose of Pfizer". It was not reported if an autopsy was performed.  Clinical course includes, We are sending you a piece of news that reached us this morning in case it is out of your area: A woman dies of a rare brain disorder after second dose of Pfizer withheld  a healthy withheld from withheld, died on Feb21, five months after receiving her second dose of Pfizer's COVID-19. The information published is all the information we have.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: A woman dies of a rare brain disorder after second dose of Pfizer
Discomfort at inj. site. Rash, warm, non painful, non itching started after 24 hours. Not fully resolved at day 7 used over the counter pain patch on that arm at some point.
Caller was audibly coughing while on the phone; Feeling wore out; No energy; Loss of equilibrium; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 62-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Sep2021 14:30 (Lot number: FC3181) at the age of 62 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "COPD" (ongoing), notes: Diagnosed about 5-6 years ago; "Heart stents" (unspecified if ongoing), notes: Received them about 6 years ago. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 01Sep2021 15:30, outcome "not recovered", described as "Feeling wore out"; ASTHENIA (non-serious) with onset 01Sep2021 15:30, outcome "not recovered", described as "No energy"; BALANCE DISORDER (non-serious) with onset 01Sep2021 15:30, outcome "not recovered", described as "Loss of equilibrium"; COUGH (non-serious), outcome "unknown", described as "Caller was audibly coughing while on the phone".  Additional information: Prior Vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was none. Adverse events following prior vaccinations was none. Family medical history relevant to adverse events was none. Caller was a consumer that reported that he got the Pfizer Covid-19 vaccine on 01Sep2021 and ever since then he was feeling wore out, has no energy, and has a loss of equilibrium. He said that he could not work. He said that he has to be able to lay down. He stated that it has to be side effects from the vaccine. Caller was audibly coughing while on the phone. Vaccination facility type was pharmacy. Adverse events do not require a visit to emergency room and physician office. Relevant tests were none. Caller said that he wanted to get in to see the doctor, but they told him that he had to call us before they would see him. No statement needed-f/u will be conducted.   Follow-up attempts are completed. No further information is expected.
Patient came in for Pfizer Bivalent vaccination.  Upon administration of vaccine, there was no sign of bleeding.  The patient waited the 15 minute period of observation in our lobby and left without adverse events.  About 15-30 minutes after leaving, the patient came back in and was bleeding abnormally from the site of injection (left deltoid).  He had bled through his bandage, through his shirt, and blood was running down his arm.  We quickly cleaned his arm, applied pressure to stop the bleeding, and wrapped his arm with gauze and tape.  Him and his wife (who also was vaccinated) were instructed to go to the emergency room if bleeding did not stop.
28 hours after getting flu vaccine I developed fever 101, chills, headache, achiness. Lasted for approx 40 hours. Treated with Acetaminophen and cold cloths on forehead.
THIS IS NOW ABOUT 2 WEEKS AFTER THE SHOT, AND MY ARM BEGAN HURTING AGAIN, THERE IS A VISIBLE AREA OF REDNESS ABOUT 4-5 INCHES LONG, LIKE A PLUME, AND IT IS HOT
had 2 diameter area around inj site rt arm urticaria rash;no itching;no resp distress-gave DPH w/in 1hr rash gone;
Patient started to develop little bumps on her face. It spread to her stomach and back then down to her legs.
funny taste in mouth, then 5 minutes later throat tingly. was given Benadryl x2 @ 14:35, at 15:04 patient reports no change. At 15:25 top of throat taste only, fullness in throat gone, at 15:35 patient normal and returned to work
Left sided neck pain, started at midnight on 6/13/12. Vaccines given afternoon of 6/12/12.
Child has swollen arm, warm to touch. No fever. Give TYLENOL and ice affected area as needed.
Pt got pfizer on 9 JUN @1100. c/o headache, bodyache and fever at this visit. Highest temp was checked at home around 38.3C-38.5C per pt. Last dosage of tylenol 500mg was 1100 today. c/o fronta/temporal headache. Denies blurry vision or vision change.
Breakthrough Varicella disease in a previously vaccinated 11 yo male. Afebrile: 10 lesions on right upper arm, 2 on neck and upper back.
The child is a 14 month old female whose mother called on 2/25 and spoke with RN, Mother advised child had "chickenpox" after vaccinations on 2/12. Child has no doctor. I advised that I would see patient today. Today, mother brings child to clinic. The following history was obtained. Family just moved to another state in 11/08. On 2/12 child received the following vaccines at the health center, PREVNAR, MMR and Varicella. Child did well until: 2/21: new onset fever with T=101.6; 02/22: fever continued but did not take temp; 2/23: rash started around face and in mouth; 2/24: rash spread "head to toe"; 2/25: rash unchanged; 2/26: rash "not as red". Child appears to be improving. Still has runny nose. Child lives at home with parents and 3 siblings, aged 18, 11 and 6. All siblings fully vaccinated according to mother. Child does not attend day care and no other children visit the home. Child has no prior vaccination adverse effects. Child is healthy with no underlying diseases, allergies, medications or surgeries. There has been no prior adverse vaccination effects. Child active, no distress. Skin: multiple small distinct nodular lesions covering essentially the entire body. Present on the face, scalp, neck, chest, abdomen, back, and extremities. No hives, vesicles, edema, ulcerations, or pox lesion. No particular lesions at any of the 4 injection sites. Assess: Rash of unknown etiology.  The timing of the symptoms of fever followed by rash started 89 days after receiving 4 vaccines (Nib, PREVNAR, MMR and Varicella). Thus, it possibly could be vaccine associated. However, I do not think the child has chickenpox. There are no pox lesions present. The lesions are fine, nodular lesions. My best estimate is that the rash is due to either Roseola or Coxsackie virus. The mother believes the rash is chickenpox. I advised that even if so, the child should receive the second dose of Varicella vaccine at age 4 - 6 years of age (see attached email from health care provider). AVEENO for skin. Child should continue to receive all scheduled vaccines. there is no reason to defer any vaccine based upon the above incident. Correction: The second paragraph of the assessment should state: "My best estimate is that the rash is due to rubella or coxsackie virus." I do NOT think the child has roseola as erroneously stated in the assessment.
Information has been received from a Licensed Practical Nurse for the Pregnancy Registry for GARDASIL, concerning her 19 year old daughter with asthma and scoliosis who on 17-OCT-2007 was vaccinated intramuscularly with a first dose of GARDASIL (lot # not reported). The nurse reported that her daughter received her first dose of GARDASIL and afterwards experienced irregular period with spotting. On 23-JAN-2008 the patient was vaccinated intramuscularly with her second dose of GARDASIL (lot # not reported) and the patient reported that her period was "not right". The patient believes her LMP was 21-FEB-2008. Concomitant therapy included YAZ, ascorbic acid, cyanocobalamin, omega-3 marine triglycerides and iron (unspecified). The patient also reported that she took YAZ at night time and she forgot to take it one night but then took it the next morning. The patient's mother believes that the birth control failed because of GARDASIL. The mother also reported that the patient was taking YAZ while she was pregnant. An ultrasound on 13-MAY-2008 showed that the patient was 8 weeks 4 days pregnant. Additional information has been requested.
Information regarding PREVNAR was received from a healthcare professional regarding a patient between 12 and 18 months of age (gender not provided) who experienced pneumococcal bacteremia. The patient received the fourth dose on an unspecified date. Relevant medical history was not provided. Product was administered on an unspecified date. Dose regimen was 1 dose 1 time per day (intramuscular). Concomitant medications were not reported. On 01-Jan-2008, the patient experienced life threatening pneumococcal bacteremia (drug ineffective) and was hospitalized. Testing revealed a blood culture positive for pneumococcus. Information regarding treatment was not provided. On an unspecified date, the patient recovered. Blood culture (results: positive for pneumococcus) was done on 01-Jan-2008. See related case(s): US-WYE-H02022008 (adverse event, expedited). No additional information was available at the time of this report. Additional information was received from the pediatrician which updated patient details, product details and event details. Information regarding PREVNAR was received from a healthcare professional regarding a 11-month-old, male patient who experienced pneumococcal bacteremia. The patient received the third dose of 01-Aug-2007. On 30-Dec-2007, the patient experienced life threatening pneumococcal bacteremia and was hospitalized. Testing revealed a blood culture positive for pneumococcus. Information regarding treatment was not provided. On an unspecified date, the patient recovered.
General aching, rib pain. Referred to her Dr. for follow up. Then 10/14/11 called in to complain of worsening symptoms of back ache, can't breathe, gasping for air at times. L arm hurting where the flu shot was given. Referred to her physician again to follow up.
Chest Pains that lead to hospitalization. Found an elevated troponin related to myocarditis. Ongoing evaluation
This case was reported by a nurse via call center representative and described the occurrence of therapy non-responder in a patient  who received TWINRIX adult. On an unknown date, the patient received TWINRIX adult. On an unknown time after receiving TWINRIX adult, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown. It was unknown if the reporter considered the therapy non-responder to be related to TWINRIX adult. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional reported that following a series of TWINRIX the patient did not develop an adequate titer following vaccination. This led to therapy non responder. The healthcare professional was unsure which titers were drawn (Hepatitis A, Hepatitis B, or both). The healthcare professional did not have vaccine information or dates of vaccination, date the titer was drawn, which titers were drawn or patient demographics.
huge cold sore in my upper lip, between the lip and nose; sick; This is a spontaneous report from a contactable consumer or other non hcp. A 79 and a half years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 27Jan2021 (at the age of 79 and a half years-old) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced a huge cold sore in her upper lip, between the lip and nose on past Friday (05Feb2021), had a sick Friday (05Feb2021), and yesterday this thing. The patient stated that she was scheduled for second dose on Wednesday, 17Feb2021. She wondered if she should go for the next appointment. The clinical outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Unexplainable dizziness, lightheadedness, body tingling, ringing in ears, fainting, rapid heart beat, unable to focus. All began a few weeks after shot and have not gone away.
Initial report received on 06 October 2008 from a health care professional.  A 48 year old female patient with asthma, received on 30 September 2008 an intramuscular dose of ADACEL (lot# C2998BA), into the right deltoid.  No other vaccines were given.  The same day of vaccination, the patient experienced redness, itching and warmth from injection site to elbow.  Approximately 3 days after, she experienced wheezing and asthma flare-up.  The patient medical history also included hyperlipidemia, osteopenia and depression.  On 23 September 2008, 7 days prior to vaccination she was treated with SOLUMEDROL 125 mg for asthma flare up.  It was reported that she required a doctor visit.  At the time of the report, she was treated with prednisone and the wheezing persisted.  It was unknown when she received her previous Td vaccination.  The reporter denied adverse events following previous vaccinations.  The patient's concomitant medications also included: Albuterol, calcium with vitamin D and citalopram 20 mg.  The patient did not recover.
Patient was vaccinated with first dose of Pfizer on 4/1/2021. Patient reports having no known allergies and no known chronic medical conditions. He states he experienced his "cheeks go numb" an hour following his first dose of the Pfizer vaccine. This symptom lasted 3-4 minutes. He denies having taken or consumed anything that would have brought on these symptoms. The numbness resolved on its own without medication. Patient consulted with primary care provider following adverse event.
196 patients received 0.25mL of Moderna Covid-19 vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 vaccine, Bivalent).    No concomitant medications were reported. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Patient received additional booster dose. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live Significant follow up received: age group and case narrative updated.
Blanching papular rash over trunk, chest, abdomen, back; few (?) blister on hand. (+) Fever began 3/5/2012 evening. Rash began 1-2 days later. Of note goes to day care w/exposure to hand foot mouth disease.
Information has been received from a RPH concerning a 13 month old male pt who on 8/27/99 was vaccinated with 1st dose of MMR. On 9/3/99, the pt was presented to a physician with low-grade fever and generalized papular urticarial rash. Subsequently, the pt's fever subsided. On 9/5/99, the pt's mother noticed that some rash spots had blanched as well as pressure on torso and extremities. At the time of the report, the pt's rashes were resolving. No further information is available.
pt recv vax & that evening pt devel swelling, redness, & tenderness @ the site of vax;2 days later pt entire left arm was swollen to twice its normal size, red & tender;26SEP96 pt dx w/pneumonia;